Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adam Bressler, MD
Atlanta Institute for Medical Research
Principal Investigator - Bradley Allen, MD
Richard L. Roudebush VA Medical Center
Principal Investigator - Carol Kauffman, MD
John D. Dingell VAMC
Principal Investigator - Daniel Musher, MD
Michael E. Debakey VAMC
Principal Investigator - David Rand, MD
Torrence Memorial Hospital
Principal Investigator - James Grendell, MD
Winthrop University Hospital
Principal Investigator - Julia Garcia-Diaz, MD
Oschner Clinic Foundation
Principal Investigator - Partha Nandi, MD
Center for Digestive Health
Principal Investigator - Wesley Bray, MD
Wellstar Clinical Trials
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Torrance Memorial Hospital
Torrance, California, United States
- Bay Pines Vamc
Bay Pines, Florida, United States
- Atlanta Institute for Medical Research
Atlanta, Georgia, United States
- Wellstar Clinical Trials
Atlanta, Georgia, United States
- Richard L. Roudebush Vamc
Indianapolis, Indiana, United States
- Oschner Clinic Foundation
New Orleans, Louisiana, United States
- John D. Dingell Vamc
Ann Arbor, Michigan, United States
- Center for Digestive Health
Troy, Michigan, United States
- Winthrop University Hospital
Mineola, New York, United States
- Michael E. Debakey Vamc
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2006
- Primary completion
- 31 Oct 2007
- Completion
- 31 Oct 2007
- Last update posted
- 5 May 2015
- Registered enrollment
- 50
- Registry id
- NCT00384527
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.